Showing results (81-90 of 406) with videos related to

Sort By:
Pageof 41
European Journal of Cancer (Oxford, England : 1990)|December 17, 2009
VEGF signalling inhibition-induced proteinuria: Mechanisms, significance and managementHassane Izzedine, Christophe Massard, Jean Philippe Spano, et al.
EXCLI Journal|June 14, 2021
Notch inhibitors induce diarrhea, hypercrinia and secretory cell metaplasia in the human colonMichael Collins, Jean-Marie Michot, Christophe Bellanger, et al.
Nature Reviews. Clinical Oncology|October 27, 2018
Hyperprogressive disease: recognizing a novel pattern to improve patient managementStéphane Champiat, Roberto Ferrara, Christophe Massard, et al.
Oncology Research and Treatment|June 6, 2015
Late recurrent testicular seminoma: histological evidence is requiredCedric Lebacle, Marco Gizzi, Jean-Marie Michot, et al.
Bulletin Du Cancer|October 9, 2014
[FRancilian Oncogeriatric Group (FROG)'s focus on management of elderly patients with bladder cancer]Djamel Ghebriou, Danièle Avenin, Philippe Caillet, et al.
Bulletin Du Cancer|April 2, 2016
[What's next in glioblastoma treatment: Tumor-targeted or immune-targeted therapies?]Antoine Schernberg, Aurélien Marabelle, Christophe Massard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2019
Facts and New Hopes on Selective FGFR Inhibitors in Solid TumorsFrancesco Facchinetti, Antoine Hollebecque, Rastislav Bahleda, et al.
Investigational New Drugs|April 4, 2009
Proteinuria and proximal tubule lesions induced by an anti-integrin monoclonal antibody treatment: case reportAndrea Gombos, Hassan Izzedine, Benjamin Besse, et al.
Current Oncology (Toronto, Ont.)|February 24, 2022
Clinical Benefit of Pembrolizumab in Advanced Urothelial Cancer Patients in Real-Life Setting: An Efficacy and Safety Monocentric StudyElodie Dang, Alexandre Vallée, Coralie Lepage-Seydoux, et al.
Pageof 41